Because the kidneys are vasodilated and the endogenous production of nitric oxide is increased in gravid rats, we tested whether nitric oxide mediates the renal vasodilatory response to pregnancy. Chronically instrumented, conscious rats of gestational days 12-14 were studied concurrently with age-matched virgin control animals. GFR and effective renal plasma flow (ERPF) were determined by the renal clearances of inulin and para-aminohippurate before and during acute infusion of NW-nitro-L-arginine methyl ester (NAME; 2, 20, and 50 jag/min) or NG-monomethyl-L-arginine (100 jag/min). Baseline GFR and ERPF were significantly increased, and effective renal vascular resistance was decreased by 30-40% in gravid rats compared with virgin controls. During infusion of all three dosages of NAME and NG-monomethyl-L-arginine, effective renal vascular resistance, GFR, and ERPF were equalized in the pregnant and virgin rats (the only exception being GFR during the 20 jag/min NAME infusion). When compared with virgin rats, the gravid animals were more responsive to nitric oxide synthase inhibition, showing a significantly greater decline in GFR and ERPF and rise in effective renal vascular resistance at each timepoint during the infusion of inhibitor. To exclude the possibility that nonspecific renal vasoconstriction per se led to equalization of renal function in the two groups of rats, we investigated angiotensin II. In contrast to the results observed with nitric oxide synthase inhibitors, pregnant rats were less responsive to the renal vasoconstrictory effects of angiotensin II, such that the baseline differences in renal parameters measured before infusion of the hormone were increased during the infusion. To determine whether nitric oxide synthase was inhibited to a similar extent in gravid and virgin rats, aortic and renal cortical cGMP content was assayed ex vivo at the end of inhibitor infusion. The lower 2-pag/min dose of NAME consistently reduced cGMP content of these tissues to comparable levels in the two groups of rats. In conclusion, we suggest that Receivedfor publication 20 December 1994 and accepted in revised form 14 March 1995. nitric oxide mediates reduced renal vascular resistance and hyperfiltration during pregnancy in conscious rats. (J. Clin. Invest. 1995. 96:482-490.)
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Introduction
Profound vasodilation of the maternal circulation typifies normal human gestation. The renal vascular bed participates in this vasodilatory response to pregnancy. Both renal blood flow and glomerular filtration rate peak at 40-80% above preconception values during the late first or early second trimester (reviewed in reference 1) . Moreover, renal blood flow rises in the face of a 5-to 10-mmHg decline in blood pressure (2) , underscoring the marked fall in renal vascular resistance that occurs during human pregnancy. The chronically instrumented conscious rat undergoes alterations in renal function during pregnancy that are comparable with those observed in gravid women. Both glomerular filtration rate and renal blood flow increase in early pregnancy and peak during midgestation at 20-40% above preconception values (3) . Like human pregnancy, the rise in renal blood flow and glomerular filtration rate is secondary to a fall in renal vascular resistance. Although renal vasodilation in pregnancy is likely to be under endocrinologic control, the hormones or autocoids involved remain unknown. In this regard, earlier work demonstrated that vasodilatory prostaglandins are unlikely to mediate the renal hemodynamic changes of rat pregnancy (4) (5) (6) .
Other endothelial-derived vasodilators, however, may be involved. We postulated that the elevated plasma level, urinary excretion, and "metabolic production" of cGMP observed in rat gestation reflect enhanced biosynthesis of endothelium-derived relaxing factor or nitric oxide (7, 8) . This hypothesis has been recently substantiated (9) . Because the kidneys are vasodilated in gravid rats and the endogenous production of nitric oxide is increased, we tested whether nitric oxide mediates the renal vasodilatory response to pregnancy. Demonstration of a critical role for nitric oxide in the maternal vasodilatory responses of normal pregnancy would strengthen the hypothesis that deficient nitric oxide production contributes to vasoconstriction of the kidney and other vascular beds in preeclampsia.
Methods
Animal preparation. Female Long-Evans rats aged 12-14 wk were purchased from Harlan Sprague-Dawley (Indianapolis, IN) and fed Harlan Teklad Rodent Chow #8604 containing 0.31% sodium. The rats were habituated to a Plexiglas restraining cage on at least five different occasions, each lasting several hours, before surgical preparation. This experimental cage was especially designed to accomodate the swollen abdomen of gravid rats and to allow for grooming of the face and front paws while preventing the rat from turning around. Thus, accurate timed urine collections were possible via the chronically implanted bladder catheter (see below). Rats that failed to habituate to the cage (< 5% of all animals) were eliminated from the study. Details of the surgical procedure have been previously described (3, 4) .
In brief, under ketamine (6.0 mg/ 100 g body weight) and pentobarbital sodium (2.1 mg/100 g body weight) anesthesia, Tygon catheters (0.015 in ID, 0.030 in OD; Norton, Akron, OH) were implanted in the abdominal aorta and inferior vena cava via the femoral artery and vein, respectively. The tips of these catheters lay below the level of the renal vessels. The catheters were then routed subcutaneously, exteriorized between the scapulae, filled with a dextrose-heparin mixture, and plugged with stainless steel pins. A cannula of silastic-covered stainless steel was then sewn into the urinary bladder with a purse string suture and exteriorized through the ventral abdominal wall. The bladder cannula was stoppered with a silastic-covered 18-gauge pin so that the rat voided through the urethra while in her home cage. During experiments, the obturator was removed for urine collection. All surgical procedures were performed using aseptic technique. The rats were housed individually after surgery and allowed a minimum of 7 ERVR, effective renal vascular resistance; MAP, mean arterial pressure; NAME, Nw-nitro-L-arginine methyl ester; NMA, N0-monomethyl-Larginine.
1 (3 ng/min) was next begun. After another 60-min equilibration period by which time blood pressure had stabilized, four additional 30-min renal clearances were conducted. After the last renal clearance period, the rats were anesthetized with pentobarbital sodium (6 mg/100 g body weight), and the aorta and kidneys were rapidly excised, rinsed in cold PBS, flash frozen in liquid nitrogen, and stored at -800C until assay for cGMP. Time-control experiments showing the stability of renal hemodynamics and glomerular filtration rate in this rat preparation have been previously published by us (4, 10). Tissue cGMP. A 2-cm length of aorta was homogenized in 1.0 ml of ice-cold 0.6 N perchloric acid. After centrifugation at 3,000 g for 10 min at 40C, the pellet was frozen at -200C for determination of protein.
The supernatant was neutralized with 5.0 N KOH. After another centrifugation to pellet the KC104, the supernatant was frozen at -200C for subsequent measurement of cGMP by radioimmunoassay. Identical procedures were used to process two 0.5-mm slices of renal cortex taken from each kidney with a Stadie-Riggs microtome (Thomas Scientific). Procedural (Table  I) were analyzed by unpaired Student's t tests. All other data were analyzed by two-factor univariate ANOVA. If significant main effects were observed, then individual group means were contrasted by the Tukey test (14) . P < 0.05 was taken to be significant. Table I summarizes baseline values for all of the virgin and midterm pregnant rats studied. In particular, both GFR and effective renal plasma flow (ERPF) were significantly increased by 30-40% in the gravid rats when compared with virgin control animals. Furthermore, effective renal vascular resistance (ERVR) was significantly decreased by a similar degree in the pregnant animals.
Results
The impact of nitric oxide synthase inhibition on renal function and blood pressure using the arginine analogue, NAME, is depicted in Figs. 1 and 2 . Averaged results are shown in Fig.   1 . With each dosage of NAME, blood pressure significantly increased in midterm pregnant and virgin rats reaching a plateau after 60 min of infusion. With the lowest dosage of NAME (2 jg/min), mean arterial pressure (MAP) rose by 5-10 mmHg, whereas the highest dosage (50 jig/min) produced elevations of 30-40 mmHg. Before infusion of the nitric oxide synthase inhibitor, GFR and ERPF were greater and ERVR was less in the gravid rats when compared with the virgin animals (P < 0.01). During infusion of each of the three doses of NAME, these renal parameters were equalized in the two groups of rats. (Table II and Fig.  3) . Inspection of the time course data (Fig. 3) reveals that the midterm pregnant rats were more responsive to inhibition of nitric oxide synthase with NMA, as they showed a greater decline in GFR and ERPF and rise in ERVR than virgin control animals. Thus, GFR, ERPF, and ERVR were equalized during the 100-btg/min infusion of NMA (Table II) .
Nitric Oxide and Renal Function in Conscious Pregnant Rats
To exclude the possibility that nonspecific renal vasoconstriction per se led to equalization of renal function in gravid and virgin rats, we tested the response to angiotensin II. Table  III and Fig. 4 depict the average and time course, respectively, of blood pressure and renal responses to the vasoconstrictor hormone infused at 3 ng/min. MAP rose by 30-40 mmHg in both groups of rats. In contrast to the results obtained with nitric oxide synthase inhibitors, the pregnant rats were less responsive to the vasoconstrictory effects of angiotensin II (Fig. 4) that baseline differences in renal parameters measured before infusion of the hormone were magnified during the infusion (Table III) . To determine whether nitric oxide synthase was inhibited to a similar extent in the gravid and virgin rats, we killed the animals at the end of the inhibitor infusion and assayed cGMP content in the aorta and kidney cortex ex vivo (Table IV) . Because cGMP is a second messenger molecule of nitric oxide generated by soluble guanylate cyclase, we measured tissue cGMP levels as a sensitive bioassay of nitric oxide activity. Additional virgin and pregnant rats were used to provide control values. Baseline cGMP content of aorta and kidney cortex was not significantly different between the two groups of rats. The lower 2-jig/min dose of NAME consistently reduced cGMP content of aorta and kidney to comparable levels in the midterm pregnant and virgin rats.
Discussion
Most mammalian species, including the rat and the human, manifest renal vasodilation and hyperfiltration during pregnancy (reviewed in references 1 and 7). In the present study, we corroborated these findings for conscious gravid rats (Table I) . Because endogenous production of nitric oxide and its second messenger, cGMP, are increased during gestation in rats (7-9), we reasoned that this potent vasodilatory system may mediate renal vasodilation and hyperfiltration of pregnancy. The objective of the present work, therefore, was to test this hypothesis. The major findings were as follows: (a) several dosages of the nitric oxide synthase inhibitor, NAME, acutely equalized effective renal plasma flow and renal vascular (18) . One of the few conditions which does recapitulate the renal hemodynamic changes of pregnancy is chronic expansion of total body water produced by continuous administration of arginine vasopressin or oxytocin (reviewed in reference 19). Whether the mechanisms responsible for marked elevation of ERPF and GFR in the two conditions are related, however, is unknown.
Renal innervation is apparently unnecessary for renal hyperfiltration during pregnancy, as the response is also observed in women with renal allografts (20) . Baylis and Blantz (21) postulated that suppression of tubuloglomerular feedback activity by plasma volume expansion may contribute to renal vasodilation and hyperfiltration of pregnancy. Pregnancy, however, did not suppress tubuloglomerular feedback in the rat, rather the mechanism was reset at a higher single nephron glomerular filtration rate. These results suggest that the expanded plasma volume of pregnancy is actually sensed as being normal presumably because of increased vascular capacity.
Ultimately, renal vasodilation in pregnancy is likely to be under endocrinologic control. Unfortunately, so many hormonal systems change that it is difficult to know which ones deserve investigation in this regard. Nevertheless, when administered to nonpregnant women, progesterone significantly increased ERPF and GFR (22, 23) . Prolactin has also been considered, but the reports of its effects on ERPF and GFR in rats are conflicting, and further investigation is needed (reviewed in reference 7). Placental lactogen, a hormone that has considerable homology with prolactin, may also warrant study. On the other hand, a maternal factor or hormone is apparently sufficient, because increases in ERPF and GFR have been documented in pseudopregnant rats (24, 25) . By mating a female rat which a vasectomized male, pseudopregnancy, a condition which physiologically mimics the first half of gestation but lacks fetoplacental development, is produced.
Other possible candidates include various endothelial factors such as vasodilatory PGs, endothelium-derived relaxing factor or nitric oxide, and endothelium-derived hyperpolarizing factor. The potential role of PGs has been tested in gravid animal models. Gestational increases in ERPF and/or GFR were unaffected by administration of cyclooxygenase inhibitors to conscious pregnant rabbits (26) and rats (4, 5) . Moreover, measurements of vasodilatory PG production by relevant renal tissues ex vivo failed to show increased synthesis by the tissues from pregnant animals (6, 27) . A role for vasodilatory PGs in the gestational elevation of ERPF and GFR, therefore, seems doubtful. On the other hand, a role for another endotheliumderived vasodilator, nitric oxide, and its second messenger, cGMP (7) (8) (9) , is possible and addressed by the current investigation. Alternatively, it may not be change of endothelial function alone that mediates renal vasodilation during pregnancy but rather modification of vascular smooth muscle may contribute (28) .
Various isoforms of nitric oxide synthase have been localized to renal tubules and blood vessels by immunohistochemistry or after microdissection by PCR (reviewed in reference 29). Thus, the potential for nitric oxide modulation of glomerular and tubular function is established. By acutely administering nitric oxide synthase inhibitors (analogues of L-arginine), numerous investigators have documented the importance of nitric oxide in the maintenance of renal vascular tone in nongravid animals, including the conscious rat (e.g., 30, 31 ). Nitric oxide was also found to modulate vascular tone and GFR in the isolated perfused rat kidney (32) . Renal vasoconstriction produced by acute nitric oxide synthase inhibition was reversible by Larginine (30) (31) (32) and not related to endogenous angiotensin II (33, 34) . Whether renal vasoconstriction produced by acute nitric oxide synthase inhibition is dependent on renal nerve activity remains controversial (34) (35) (36) . Renal micropuncture studies in anesthetized rats showed that intravenous administration of NMA leading to large increases of blood pressure produced a rise in both preglomerular and efferent arteriolar resistances as well as in glomerular hydrostatic pressure and a fall in the glomerular capillary ultrafiltration coefficient (Kf); in one study, glomerular plasma flow declined relatively more than single nephron glomerular filtration rate (37) , whereas in another, single nephron GFR did not fall at all (38) . Lower dosages of NMA administered directly into the renal artery leading to smaller increases of blood pressure produced a rise only in preglomerular arteriolar resistance and a fall in Kf such that a greater decline was noted for single nephron GFR relative to glomerular plasma flow in this setting (37) . Nitric oxide was also reported to modulate vascular tone of isolated perfused juxtamedullary interlobular, afferent, and efferent arterioles from the rat (39, 40) .
In the present study, three different dosages of NAME were administered, leading to elevations of MAP ranging from 5 to 50 mmHg. The changes in renal function of virgin rats were similar to those previously reported (30, 31) . That is, marked renal vasoconstriction concommittant with a decline in ERPF, relative maintenance of GFR, and a steep rise in filtration fraction were observed ( Figs. 1 and 2 , and see Results). Identical findings were obtained with NMA (Table II and Fig. 3 ). For the midterm pregnant rats, however, GFR also declined during nitric oxide synthase blockade (Figs. 1-3 and Table II ). Despite this decline in GFR, a rise in filtration fraction comparable with virgin rats was observed, because ERPF declined relatively more than GFR in the gravid animals (Figs. 1-3 and Table  H , and see Results). Although micropuncture experiments are clearly needed, these data suggest that the nitric oxide synthase inhibitors affected the glomerular microcirculation differently in virgin and midterm pregnant rats. Whereas efferent arteriolar constriction was most notable in virgin rats leading to relative maintenance of GFR despite a decline in ERPF, preglomerular arteriolar constriction was most notable in gravid animals as GFR was not maintained in the face of a decline in ERPF. Alternatively, Kf may have been decreased to a greater extent in the pregnant rats. In either case, the finding that ERPF and GFR were equalized in gravid and virgin rats by nitric oxide synthase blockade strongly suggests that nitric oxide mediates gestational hyperfiltration and renal vasodilation. Nitric oxide may act both directly on the renal microcirculation and, possibly, indirectly by modulating renal sympathetic nerve activity (34) (35) (36) , thereby dilating the renal arterioles in pregnancy. An indirect effect by modulation of renal sympathetic activity seems less likely, however, because gestational hyperfiltration is apparently independent of renal innervation (at least in women) (20) .
To approximate the extent of nitric oxide synthase blockade in the midterm pregnant and virgin rats, we measured aortic and renal cortical cGMP content ex vivo as a bioassay of tissue nitric oxide synthase activity (41) . We found that the low dose of NAME (2 tzg/min), which produced only modest increases of blood pressure, consistently reduced tissue cGMP content to comparable levels in the two groups of rats (Table IV) . Thus, comparable blockade of nitric oxide synthase was most likely achieved by our infusion protocol. On the other hand, higher doses of NAME and NMA, which markedly increased blood pressure, failed to consistently reduce tissue cGMP content in either group of rats. Because atrial natriuretic hormone release is augmented by increases of blood pressure, this finding may relate to the overriding effect of the hormone on tissue particulate guanylate cyclase (41) . At the higher doses of nitric oxide synthase inhibitor, therefore, tissue cGMP content is apparently no longer a reliable index of nitric oxide synthase activity.
Of additional interest are the data showing that basal levels of renal and aortic cGMP content are not significantly different between the virgin and gravid rats (Table IV) . This observation corroborates our previous work in which we systematically measured basal cGMP of aortic tissue in the presence and absence of endothelium, hemoglobin, phosphodiesterase inhibitors, and L-arginine (42) . No differences in cGMP content between virgin and gravid rats were detected in any of these treatments. We concluded that basal production of nitric oxide synthase is comparable in aortae from virgin and pregnant rats at least when assessed by cGMP bioassay ex vivo, and the inducible isozyme is not expressed during gestation. Thus, the continuous presence of some factor in vivo may be required for enhanced nitric oxide production by aorta and kidney cortical tissues in gravid rats. Alternatively, because renal cortical tissue is mainly comprised of tubules, augmented nitric oxide production by the microvasculature affecting hemodynamic changes may not have been detectable by our bioassay. Conceivably, enhanced biosynthesis of nitric oxide and cGMP during rat gestation may effect long-lived modification of vessel function, which can persist for some time despite reduction of endothelial nitric oxide production and vascular cGMP content to nonpregnant levels.
To exclude the possibility that renal vasoconstriction per se led to the normalization of renal function in gravid rats by a nonspecific mechanism, we also tested the response to angiotensin HI. In contrast to the vasoconstriction produced by nitric oxide synthase inhibitors, midterm pregnant rats were less responsive to angiotensin II than virgin animals, such that the baseline differences in renal function between the two groups of rats were actually enhanced during infusion of the hormone (Table HI and Fig. 4 ). Attenuation of renal vascular reactivity to angiotensin H has been previously reported for conscious pregnant rats during late pregnancy (4) and in conscious gravid rabbits (43) , although not all investigators have reported an attenuated response (44) . The decrement of GFR in response to angiotensin H was also diminished in pregnant women of 26-35 gestational weeks (45). We speculate that the attenuation of renal vascular responses to angiotensin H during rat gestation is mediated by nitric oxide. [ We previously reported that it is not dependent on vasodilatory prostaglandins (4) .] The resistance to the systemic pressor effect of angiotensin H is not consistently observed until late gestation in rats (4) .
To our knowledge, the contribution of nitric oxide to reduced vascular tone and increased blood flow in other organs during pregnancy has not been investigated. Teleologically speaking, reduced vascular tone in nonreproductive vascular beds such as the kidney serves to reduce total systemic vascular resistance and blood pressure, which stimulates sodium appetite and thirst as well as renal retention of sodium and water (46) . These factors allow for expansion of plasma volume, which in turn abets the increase of cardiac output and ultimately of oxygen and nutrient delivery to the fetus and placenta. In previous work, we identified increased biosynthesis of nitric oxide and cGMP during gestation in rats (7) (8) (9) . In the present study, we provide evidence that nitric oxide mediates the reduction in renal vascular resistance during pregnancy in this species. If this finding pertains to women, then a deficiency of nitric oxide production may account for the reductions in ERPF and GFR observed in preeclampsia (see reference 47 for review). Clearly, further investigation is needed to identify the stimulus for enhanced biosynthesis of nitric oxide in the kidney during gestation and to determine whether nitric oxide synthase protein and mRNA expression are increased and, if so, by which renal anatomical structures.
